Atlas Growth Acquisition, a blank check company targeting Asian healthcare and TMT, filed on Wednesday with the SEC to raise up to $110 million in an initial public offering.
The Hong Kong, China-based company plans to raise $110 million by offering 11 million units at $10 per unit. Each unit contains one share of common stock and one-half of a warrant, exercisable at $11.50. At the proposed deal size, the company would command a market value of $138 million.
The company is led by CEO and Chairman Sung Hwang, the CEO of private equity firm Atlas Investment Management, and CFO and Director Wai Wong, former CFO of We Doctor Greater Bay Area, a subsidiary of Chinese digital medical platform WeDoctor. The company aims to leverage management's experience to target healthcare, consumer technology, and technology, media, and telecommunications in Asia.
The company was founded in 2021 and plans to list on the Nasdaq under the symbol ATLAU. Ladenburg Thalmann, and Brookline Capital Markets are the joint bookrunners on the deal.
IPO Pro - "The Ultimate Resource for IPOs"
Don't risk buying another IPO without IPO Pro.
Get your FREE TRIAL now.
